Cedar Hill Associates LLC cut its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 7.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 56,080 shares of the medical research company’s stock after selling 4,304 shares during the quarter. Thermo Fisher Scientific accounts for approximately 1.9% of Cedar Hill Associates LLC’s holdings, making the stock its 19th biggest position. Cedar Hill Associates LLC’s holdings in Thermo Fisher Scientific were worth $10,648,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Icon Wealth Partners LLC acquired a new stake in Thermo Fisher Scientific in the fourth quarter valued at $105,000. Bank of Nova Scotia Trust Co. acquired a new stake in Thermo Fisher Scientific in the third quarter valued at $106,000. Keeler Thomas Management LLC acquired a new stake in Thermo Fisher Scientific in the fourth quarter valued at $106,000. Virtue Capital Management LLC acquired a new stake in Thermo Fisher Scientific in the fourth quarter valued at $127,000. Finally, Premia Global Advisors LLC acquired a new stake in Thermo Fisher Scientific in the fourth quarter valued at $131,000. 87.63% of the stock is owned by hedge funds and other institutional investors.
A number of research firms have commented on TMO. Morgan Stanley raised their target price on Thermo Fisher Scientific from $223.00 to $227.00 and gave the company an “overweight” rating in a report on Thursday, February 1st. Leerink Swann reissued an “outperform” rating and issued a $239.00 target price (up previously from $200.00) on shares of Thermo Fisher Scientific in a report on Thursday, February 1st. They noted that the move was a valuation call. Barclays raised their target price on Thermo Fisher Scientific from $225.00 to $245.00 and gave the company an “overweight” rating in a report on Thursday, February 1st. ValuEngine raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating in a report on Friday, February 2nd. Finally, BTIG Research began coverage on Thermo Fisher Scientific in a report on Friday, January 5th. They issued a “buy” rating and a $230.00 target price for the company. Two research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $220.50.
Thermo Fisher Scientific stock opened at $212.96 on Thursday. The stock has a market capitalization of $85,065.73, a price-to-earnings ratio of 38.03, a PEG ratio of 1.55 and a beta of 1.15. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.92 and a current ratio of 1.34. Thermo Fisher Scientific Inc. has a one year low of $151.74 and a one year high of $226.44.
Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings results on Wednesday, January 31st. The medical research company reported $2.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.66 by $0.13. The business had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $5.72 billion. Thermo Fisher Scientific had a return on equity of 16.01% and a net margin of 10.64%. The business’s revenue was up 22.1% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.41 EPS. research analysts forecast that Thermo Fisher Scientific Inc. will post 10.81 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, April 16th. Investors of record on Thursday, March 15th will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.32%. The ex-dividend date is Wednesday, March 14th. This is a boost from Thermo Fisher Scientific’s previous quarterly dividend of $0.15. Thermo Fisher Scientific’s dividend payout ratio (DPR) is currently 12.14%.
Thermo Fisher Scientific Company Profile
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.